Krithika (kitty) Rajagopalan PhD, MS, BS

Kitty (Krithika) Rajagopalan, B.S (Pharm), MS, PhD is a visionary leader with over 23 years of operational experience in building and leading Global & US Health Economics, Pricing, Policy and Market Access function across drugs, devices, and biologics industry. Her cross-therapeutic area Health Economics & Outcomes Research (HEOR) leadership expertise spans a wide spectrum of diseases and conditions including but not limited to psychiatry, neurology, oncology, cardio-pulmonary, respiratory, auto-immune and other rare diseases.

She owns multiple copyrights for patient reported outcomes instruments and has published over 80+ manuscripts in peer-reviewed journals. She also has presented over 600 scientific papers at meetings and is an invited speaker at DIA, ISPOR and other forums on health care topics as diverse as global reimbursement, HEOR methodologies, Patient Reported Outcomes in Clinical trials, public policy issues with the emergence of ACOs and expanded role of HEOR.